Trial · NCT05185609
Assessment of Anorectal Function in Patients With Inflammatory Bowel Disease
Active inflammatory bowel disease (IBD) causes disabling symptoms such as diarrhea, involuntary loss of bowel control, abdominal pain and urges to pass stool. H
- Status
- Recruiting
- Sponsor
- Region Örebro County
- Study type
- Observational
- Phase
- Not applicable
- Enrollment
- 70 participants (planned)
- Start
- Sep 1, 2021
- Primary completion
- Dec 30, 2027
- Conditions
- Inflammatory Bowel Diseases, Irritable Bowel Syndrome
Summary
Active inflammatory bowel disease (IBD) causes disabling symptoms such as diarrhea, involuntary loss of bowel control, abdominal pain and urges to pass stool. However, even patients with inactive IBD frequently experience such symptoms. The cause is not well understood and the functionality of the bowel in IBD patients is underexplored. Earlier studies show a wide range of results, but most find that patients with IBD in remission are up to four times as likely to report gastrointestinal symptoms when compared to healthy controls.
Interventions
- Exposure 1: Visceral hypersensitivity or phenotype suggestive of IBS Other
- Exposure 2: Changes in anorectal motor function or compliance. Other
Locations
1 country: Sweden.
| Facility | City | Country |
|---|---|---|
| University hospital Örebro | Örebro | Sweden |
TreatIBS is an informational site and does not provide medical advice. The research summarized here may not apply to your situation. Talk with a clinician before starting, stopping, or changing any treatment.
Listing only. Eligibility is decided by the study team. TreatIBS is not involved in recruitment.